<!doctype html>
<html  lang="vi">


<head>

<link rel="stylesheet" href="lite-yt-embed.css" />
<script src="lite-yt-embed.js"></script>
<meta charset="utf-8">
<meta http-equiv="x-ua-compatible" content="ie=edge">
<meta name="viewport" content="width=device-width, initial-scale=1">
<meta http-equiv="content-language" content="vi" />
<meta name="robots" content="INDEX,FOLLOW" />
<meta name="revisit-after" content="1 days" />
<title>Top 19 b-nhl cll 2022</title>
<meta name="description" content="Top 19 b-nhl cll 2022">
<meta name="keywords" th:content="b-nhl cll">
<!-- Yandex.Metrika counter -->
<script type="text/javascript" >
   (function(m,e,t,r,i,k,a){m[i]=m[i]||function(){(m[i].a=m[i].a||[]).push(arguments)};
   m[i].l=1*new Date();
   for (var j = 0; j < document.scripts.length; j++) {if (document.scripts[j].src === r) { return; }}
   k=e.createElement(t),a=e.getElementsByTagName(t)[0],k.async=1,k.src=r,a.parentNode.insertBefore(k,a)})
   (window, document, "script", "https://mc.yandex.ru/metrika/tag.js", "ym");

   ym(91687605, "init", {
        clickmap:true,
        trackLinks:true,
        accurateTrackBounce:true
   });
</script>
<noscript><div><img src="https://mc.yandex.ru/watch/91687605" style="position:absolute; left:-9999px;" alt="" /></div></noscript>
<!-- /Yandex.Metrika counter -->


<style>
#ul_content {
	list-style: disc;
}
</style>

</head>

<body
	style="width: 100%; font-family: Helvetica, Arial, sans-serif; font-size: 18px;">

	<a href="/"
		style="width: 100%; text-align: center; display: block; line-height: 100px;">Home</a>

	<div
		style="height: auto !important; max-width: 1000px; overflow: hidden; width: 96%; display: block; margin: auto; padding: 1% 1% 1% 1%;">
	<h1 style="width: 100%;height: auto;display: block;text-align: left;" >Top 19 b-nhl cll 2022 </h1>

<p class="intro" style="    font-size: 16px !important;    font-weight: bold;">Duới đây là các thông tin và kiến thức về chủ đề <a href="https://www.google.com/search?q=b-nhl+cll"> b-nhl cll </a> hay nhất do chính tay đội ngũ chúng tôi biên soạn và tổng hợp: </p>
<lite-youtube videoid="CVHwSkideuQ" style="background-image: url('https://i.ytimg.com/vi/CVHwSkideuQ/hqdefault.jpg');"> 
 <a class="lty-playbtn" title="CD20 targeted CAR-T: MB-106 in B-NHL and CLL"> <span class="lyt-visually-hidden">CD20 targeted CAR-T: MB-106 in B-NHL and CLL</span> </a>
</lite-youtube>
<p></p>
<h2 id="h2_0">1. Treating B-Cell Non-Hodgkin Lymphoma - American …</h2>
<div id="content" style="display: inline-block;background: #eff5f9;border: 1px solid #9cd5f4;border-radius: 4px;/*! width: 52%; */padding: 1.5%;margin-bottom: 10px;font-size: 14px;padding: 10px 10px 10px 20px;">
 <ul id="ul_content"> 
  <li> <p><strong>Tác giả: </strong> www.cancer.org </p></li> 
  <li> <p><strong> Ngày đăng: </strong> 22/7/2022 </p></li>
  <li> <p><strong> Lượt xem: </strong> 45574 </p></li> 
  <li> <p><strong>Đánh giá: </strong> 1 ⭐ ( 3100 lượt đánh giá ) </p></li>
  <li> <p><strong>Xếp hạng cao nhất : </strong> 5 ⭐ </p></li> 
  <li> <p><strong>Xếp hạng thấp nhất : </strong> 3 ⭐ </p></li> 
  <li> <p><strong>Mô tả bài viết: </strong><span class="content"> Non-Hodgkin lymphoma (NHL) is generally divided into 2 main types, based on whether it starts in B lymphocytes (B cells) or T lymphocytes (T cells). There are many different types of<strong> B-cell</strong> …Chemo is the main treatment for most people with non-Hodgkin lymphoma …Freedman AS, Jacobson CA, Mauch P, Aster JC. Chapter 103: Non-Hodgkin’s …Ibrutinib (Imbruvica) can be used to treat several types of NHL, including mantle …It's important to take time and think about your choices. Because CLL often grows …These are types of lymphoma that affect B lymphocytes. The most common types of …People with HIV infections are at increased risk for non-Hodgkin lymphoma. …... </span> </p> </li>
  <p style="text-align: center;"><a href="https://leadingviet.com/link-out/aHR0cHM6Ly93d3cuY2FuY2VyLm9yZy9jYW5jZXIvbm9uLWhvZGdraW4tbHltcGhvbWEvdHJlYXRpbmcvYi1jZWxsLWx5bXBob21hLmh0bWw=" style="background-color: #009dea;color: white;padding: 10px 15px;text-decoration: none;text-transform: uppercase;border-radius: 5px;text-align: center;margin: 0;"> Xem thêm</a></p>
 </ul>
</div><!--ads_tag-->
<p><br></p>
<p>
 <lite-youtube videoid="M8eq73lHu70" style="background-image: url('https://i.ytimg.com/vi/M8eq73lHu70/hqdefault.jpg');"> 
  <a class="lty-playbtn" title="Dr. Eradat on Rituximab Biosimilar in CD20+ B-Cell NHL and CLL"> <span class="lyt-visually-hidden">Dr. Eradat on Rituximab Biosimilar in CD20+ B-Cell NHL and CLL</span> </a>
 </lite-youtube></p>
<p></p>
<h2 id="h2_1">2. First Patient With B-NHL or CLL Treated With MB-106 in Phase …</h2>
<div id="content" style="display: inline-block;background: #eff5f9;border: 1px solid #9cd5f4;border-radius: 4px;/*! width: 52%; */padding: 1.5%;margin-bottom: 10px;font-size: 14px;padding: 10px 10px 10px 20px;">
 <ul id="ul_content"> 
  <li> <p><strong>Tác giả: </strong> www.targetedonc.com </p></li> 
  <li> <p><strong> Ngày đăng: </strong> 9/2/2022 </p></li>
  <li> <p><strong> Lượt xem: </strong> 42485 </p></li> 
  <li> <p><strong>Đánh giá: </strong> 5 ⭐ ( 77045 lượt đánh giá ) </p></li>
  <li> <p><strong>Xếp hạng cao nhất : </strong> 5 ⭐ </p></li> 
  <li> <p><strong>Xếp hạng thấp nhất : </strong> 2 ⭐ </p></li> 
  <li> <p><strong>Mô tả bài viết: </strong><span class="content"> <span class="news_dt">10/10/2022</span>&nbsp;· The multicenter, open-label, non-randomized, phase 1/2 study aims to evaluate the safety, tolerability, and efficacy of MB-106 in patients with relapsed or refractory B-NHL or …... </span> </p> </li>
  <p style="text-align: center;"><a href="https://leadingviet.com/link-out/aHR0cHM6Ly93d3cudGFyZ2V0ZWRvbmMuY29tL3ZpZXcvZmlyc3QtcGF0aWVudC13aXRoLWItbmhsLW9yLWNsbC10cmVhdGVkLXdpdGgtbWItMTA2LWluLXBoYXNlLTEtMi1zdHVkeQ==" style="background-color: #009dea;color: white;padding: 10px 15px;text-decoration: none;text-transform: uppercase;border-radius: 5px;text-align: center;margin: 0;"> Xem thêm</a></p>
 </ul>
</div>
<p><br></p>
<p>
 <lite-youtube videoid="nv3VRZHigkc" style="background-image: url('https://i.ytimg.com/vi/nv3VRZHigkc/hqdefault.jpg');"> 
  <a class="lty-playbtn" title="Making NHL &amp; CLL Cancer Treatment Decisions"> <span class="lyt-visually-hidden">Making NHL &amp; CLL Cancer Treatment Decisions</span> </a>
 </lite-youtube></p>
<p></p>
<h2 id="h2_2">3. Chronic Lymphocytic Leukemia (B-CLL) and Immunocytoma (LP …</h2>
<div id="content" style="display: inline-block;background: #eff5f9;border: 1px solid #9cd5f4;border-radius: 4px;/*! width: 52%; */padding: 1.5%;margin-bottom: 10px;font-size: 14px;padding: 10px 10px 10px 20px;">
 <ul id="ul_content"> 
  <li> <p><strong>Tác giả: </strong> pubmed.ncbi.nlm.nih.gov </p></li> 
  <li> <p><strong> Ngày đăng: </strong> 17/6/2022 </p></li>
  <li> <p><strong> Lượt xem: </strong> 74525 </p></li> 
  <li> <p><strong>Đánh giá: </strong> 2 ⭐ ( 98701 lượt đánh giá ) </p></li>
  <li> <p><strong>Xếp hạng cao nhất : </strong> 5 ⭐ </p></li> 
  <li> <p><strong>Xếp hạng thấp nhất : </strong> 5 ⭐ </p></li> 
  <li> <p><strong>Mô tả bài viết: </strong><span class="content"> The Kiel classification of non-Hodgkin lymphomas (<strong>NHL</strong>) has established chronic lymphocytic leukemia (<strong>B</strong>-<strong>CLL</strong>) and immunocytoma (LP-IC) as separate entities of low-grade malignant …... </span> </p> </li>
  <p style="text-align: center;"><a href="https://leadingviet.com/link-out/aHR0cHM6Ly9wdWJtZWQubmNiaS5ubG0ubmloLmdvdi8yNzQ2MzUwMS8=" style="background-color: #009dea;color: white;padding: 10px 15px;text-decoration: none;text-transform: uppercase;border-radius: 5px;text-align: center;margin: 0;"> Xem thêm</a></p>
 </ul>
</div><!--ads_tag-->
<p><br></p>
<p>
 <lite-youtube videoid="UU8a53hq2mE" style="background-image: url('https://i.ytimg.com/vi/UU8a53hq2mE/hqdefault.jpg');"> 
  <a class="lty-playbtn" title="Diffuse Large B-Cell Lymphoma (DLBCL) | Aggressive  B-Cell Non-Hodgkin’s Lymphoma"> <span class="lyt-visually-hidden">Diffuse Large B-Cell Lymphoma (DLBCL) | Aggressive B-Cell Non-Hodgkin’s Lymphoma</span> </a>
 </lite-youtube></p>
<p></p>
<h2 id="h2_3">4. First Patient With B-NHL or CLL Treated With MB-106 in Phase …</h2>
<div id="content" style="display: inline-block;background: #eff5f9;border: 1px solid #9cd5f4;border-radius: 4px;/*! width: 52%; */padding: 1.5%;margin-bottom: 10px;font-size: 14px;padding: 10px 10px 10px 20px;">
 <ul id="ul_content"> 
  <li> <p><strong>Tác giả: </strong> www.stemcell.tv </p></li> 
  <li> <p><strong> Ngày đăng: </strong> 1/2/2022 </p></li>
  <li> <p><strong> Lượt xem: </strong> 36989 </p></li> 
  <li> <p><strong>Đánh giá: </strong> 4 ⭐ ( 34956 lượt đánh giá ) </p></li>
  <li> <p><strong>Xếp hạng cao nhất : </strong> 5 ⭐ </p></li> 
  <li> <p><strong>Xếp hạng thấp nhất : </strong> 1 ⭐ </p></li> 
  <li> <p><strong>Mô tả bài viết: </strong><span class="content"> <span class="news_dt">13/10/2022</span>&nbsp;· First Patient With <strong>B-NHL</strong> or <strong>CLL</strong> Treated With MB-106 in Phase 1/2 Study – Targeted Oncology. The phase 1/2 clinical trial of MB-106 is demonstrating high efficacy, …... </span> </p> </li>
  <p style="text-align: center;"><a href="https://leadingviet.com/link-out/aHR0cHM6Ly93d3cuc3RlbWNlbGwudHYvY2VsbC10aGVyYXB5LTIvZmlyc3QtcGF0aWVudC13aXRoLWItbmhsLW9yLWNsbC10cmVhdGVkLXdpdGgtbWItMTA2LWluLXBoYXNlLTEtMi1zdHVkeS10YXJnZXRlZC1vbmNvbG9neS5waHA=" style="background-color: #009dea;color: white;padding: 10px 15px;text-decoration: none;text-transform: uppercase;border-radius: 5px;text-align: center;margin: 0;"> Xem thêm</a></p>
 </ul>
</div>
<p><br></p>
<p>
 <lite-youtube videoid="7XsfabgrPHE" style="background-image: url('https://i.ytimg.com/vi/7XsfabgrPHE/hqdefault.jpg');"> 
  <a class="lty-playbtn" title="Non-Hodgkin's lymphoma (NHL) B-cell and T-cell | Aggressive and Indolent"> <span class="lyt-visually-hidden">Non-Hodgkin's lymphoma (NHL) B-cell and T-cell | Aggressive and Indolent</span> </a>
 </lite-youtube></p>
<p></p>
<h2 id="h2_4">5. NHL Subtypes | Leukemia and Lymphoma Society</h2>
<div id="content" style="display: inline-block;background: #eff5f9;border: 1px solid #9cd5f4;border-radius: 4px;/*! width: 52%; */padding: 1.5%;margin-bottom: 10px;font-size: 14px;padding: 10px 10px 10px 20px;">
 <ul id="ul_content"> 
  <li> <p><strong>Tác giả: </strong> www.lls.org </p></li> 
  <li> <p><strong> Ngày đăng: </strong> 19/1/2022 </p></li>
  <li> <p><strong> Lượt xem: </strong> 39608 </p></li> 
  <li> <p><strong>Đánh giá: </strong> 1 ⭐ ( 61097 lượt đánh giá ) </p></li>
  <li> <p><strong>Xếp hạng cao nhất : </strong> 5 ⭐ </p></li> 
  <li> <p><strong>Xếp hạng thấp nhất : </strong> 3 ⭐ </p></li> 
  <li> <p><strong>Mô tả bài viết: </strong><span class="content"> Diffuse large<strong> B-cell lymphoma</strong> (DLBCL) is the most common aggressive NHL subtype. Indolent lymphomas are slow-moving and tend to grow more slowly and have fewer signs and …... </span> </p> </li>
  <p style="text-align: center;"><a href="https://leadingviet.com/link-out/aHR0cHM6Ly93d3cubGxzLm9yZy9seW1waG9tYS9ub24taG9kZ2tpbi1seW1waG9tYS9uaGwtc3VidHlwZXM=" style="background-color: #009dea;color: white;padding: 10px 15px;text-decoration: none;text-transform: uppercase;border-radius: 5px;text-align: center;margin: 0;"> Xem thêm</a></p>
 </ul>
</div><!--ads_tag-->
<p><br></p>
<p>
 <lite-youtube videoid="_QVO75CihYQ" style="background-image: url('https://i.ytimg.com/vi/_QVO75CihYQ/hqdefault.jpg');"> 
  <a class="lty-playbtn" title="Non-hodgkin lymphoma - causes, symptoms, diagnosis, treatment, pathology"> <span class="lyt-visually-hidden">Non-hodgkin lymphoma - causes, symptoms, diagnosis, treatment, pathology</span> </a>
 </lite-youtube></p>
<p></p>
<h2 id="h2_9">6. B-Cell Chronic Lymphocytic Leukemia - an overview</h2>
<div id="content" style="display: inline-block;background: #eff5f9;border: 1px solid #9cd5f4;border-radius: 4px;/*! width: 52%; */padding: 1.5%;margin-bottom: 10px;font-size: 14px;padding: 10px 10px 10px 20px;">
 <ul id="ul_content"> 
  <li> <p><strong>Tác giả: </strong> www.sciencedirect.com </p></li> 
  <li> <p><strong> Ngày đăng: </strong> 28/8/2022 </p></li>
  <li> <p><strong> Lượt xem: </strong> 41633 </p></li> 
  <li> <p><strong>Đánh giá: </strong> 3 ⭐ ( 75464 lượt đánh giá ) </p></li>
  <li> <p><strong>Xếp hạng cao nhất : </strong> 5 ⭐ </p></li> 
  <li> <p><strong>Xếp hạng thấp nhất : </strong> 4 ⭐ </p></li> 
  <li> <p><strong>Mô tả bài viết: </strong><span class="content"> Chronic lymphocytic leukemia (<strong>CLL</strong>) is a malignancy of CD5 + <strong>B</strong> cells that is characterized by the accumulation of small, mature-appearing neoplastic lymphocytes in the blood, marrow, and …... </span> </p> </li>
  <p style="text-align: center;"><a href="https://leadingviet.com/link-out/aHR0cHM6Ly93d3cuc2NpZW5jZWRpcmVjdC5jb20vdG9waWNzL21lZGljaW5lLWFuZC1kZW50aXN0cnkvYi1jZWxsLWNocm9uaWMtbHltcGhvY3l0aWMtbGV1a2VtaWE=" style="background-color: #009dea;color: white;padding: 10px 15px;text-decoration: none;text-transform: uppercase;border-radius: 5px;text-align: center;margin: 0;"> Xem thêm</a></p>
 </ul>
</div>
<p><br></p>
<p>
 <lite-youtube videoid="WW5zILvyats" style="background-image: url('https://i.ytimg.com/vi/WW5zILvyats/hqdefault.jpg');"> 
  <a class="lty-playbtn" title="The importance of PI3-kinase delta in CLL and NHL"> <span class="lyt-visually-hidden">The importance of PI3-kinase delta in CLL and NHL</span> </a>
 </lite-youtube></p>
<p></p>
<h2 id="h2_10">7. Non-Hodgkin’s Lymphoma and Chronic Lymphocytic …</h2>
<div id="content" style="display: inline-block;background: #eff5f9;border: 1px solid #9cd5f4;border-radius: 4px;/*! width: 52%; */padding: 1.5%;margin-bottom: 10px;font-size: 14px;padding: 10px 10px 10px 20px;">
 <ul id="ul_content"> 
  <li> <p><strong>Tác giả: </strong> link.springer.com </p></li> 
  <li> <p><strong> Ngày đăng: </strong> 7/9/2022 </p></li>
  <li> <p><strong> Lượt xem: </strong> 64307 </p></li> 
  <li> <p><strong>Đánh giá: </strong> 2 ⭐ ( 5009 lượt đánh giá ) </p></li>
  <li> <p><strong>Xếp hạng cao nhất : </strong> 5 ⭐ </p></li> 
  <li> <p><strong>Xếp hạng thấp nhất : </strong> 5 ⭐ </p></li> 
  <li> <p><strong>Mô tả bài viết: </strong><span class="content"> This chapter describes non-Hodgkin’s lymphoma (NHL) and<strong> chronic lymphocytic leukemia</strong> (CLL). NHL is a complex and heterogeneous group of disorders characterized by clonal …... </span> </p> </li>
  <p style="text-align: center;"><a href="https://leadingviet.com/link-out/aHR0cHM6Ly9saW5rLnNwcmluZ2VyLmNvbS9jaGFwdGVyLzEwLjEwMDcvOTc4LTEtNTkyNTktOTYzLTlfODI=" style="background-color: #009dea;color: white;padding: 10px 15px;text-decoration: none;text-transform: uppercase;border-radius: 5px;text-align: center;margin: 0;"> Xem thêm</a></p>
 </ul>
</div><!--ads_tag-->
<p><br></p>
<p>
 <lite-youtube videoid="5Ev8xKqi1n0" style="background-image: url('https://i.ytimg.com/vi/5Ev8xKqi1n0/hqdefault.jpg');"> 
  <a class="lty-playbtn" title="Mosunetuzumab in B-NHL R/R to CAR-T"> <span class="lyt-visually-hidden">Mosunetuzumab in B-NHL R/R to CAR-T</span> </a>
 </lite-youtube></p>
<p></p>
<h2 id="h2_11">8. Chronische lymphatische Leukämie – Wikipedia</h2>
<div id="content" style="display: inline-block;background: #eff5f9;border: 1px solid #9cd5f4;border-radius: 4px;/*! width: 52%; */padding: 1.5%;margin-bottom: 10px;font-size: 14px;padding: 10px 10px 10px 20px;">
 <ul id="ul_content"> 
  <li> <p><strong>Tác giả: </strong> de.wikipedia.org </p></li> 
  <li> <p><strong> Ngày đăng: </strong> 5/1/2022 </p></li>
  <li> <p><strong> Lượt xem: </strong> 16084 </p></li> 
  <li> <p><strong>Đánh giá: </strong> 1 ⭐ ( 1423 lượt đánh giá ) </p></li>
  <li> <p><strong>Xếp hạng cao nhất : </strong> 5 ⭐ </p></li> 
  <li> <p><strong>Xếp hạng thấp nhất : </strong> 5 ⭐ </p></li> 
  <li> <p><strong>Mô tả bài viết: </strong><span class="content"> Die chronische lymphatische Leukämie (englisch<strong> chronic lymphocytic leukemia, CLL),</strong> auch chronisch-lymphatische Leukämie genannt, ist ein niedrigmalignes, leukämisch verlaufendes B …... </span> </p> </li>
  <p style="text-align: center;"><a href="https://leadingviet.com/link-out/aHR0cHM6Ly9kZS53aWtpcGVkaWEub3JnL3dpa2kvQ2hyb25pc2NoZV9seW1waGF0aXNjaGVfTGV1ayVDMyVBNG1pZQ==" style="background-color: #009dea;color: white;padding: 10px 15px;text-decoration: none;text-transform: uppercase;border-radius: 5px;text-align: center;margin: 0;"> Xem thêm</a></p>
 </ul>
</div>
<p><br></p>
<p>
 <lite-youtube videoid="cZR6EUVnrWQ" style="background-image: url('https://i.ytimg.com/vi/cZR6EUVnrWQ/hqdefault.jpg');"> 
  <a class="lty-playbtn" title="Ublituximab, umbralisib and ibrutinib in CLL and NHL"> <span class="lyt-visually-hidden">Ublituximab, umbralisib and ibrutinib in CLL and NHL</span> </a>
 </lite-youtube></p>
<p></p>
<h2 id="h2_12">9. Abstract - American Society of Hematology</h2>
<div id="content" style="display: inline-block;background: #eff5f9;border: 1px solid #9cd5f4;border-radius: 4px;/*! width: 52%; */padding: 1.5%;margin-bottom: 10px;font-size: 14px;padding: 10px 10px 10px 20px;">
 <ul id="ul_content"> 
  <li> <p><strong>Tác giả: </strong> ashpublications.org </p></li> 
  <li> <p><strong> Ngày đăng: </strong> 12/4/2022 </p></li>
  <li> <p><strong> Lượt xem: </strong> 77135 </p></li> 
  <li> <p><strong>Đánh giá: </strong> 2 ⭐ ( 50033 lượt đánh giá ) </p></li>
  <li> <p><strong>Xếp hạng cao nhất : </strong> 5 ⭐ </p></li> 
  <li> <p><strong>Xếp hạng thấp nhất : </strong> 3 ⭐ </p></li> 
  <li> <p><strong>Mô tả bài viết: </strong><span class="content"> <span class="news_dt">05/11/2021</span>&nbsp;· CD20 is a proven target for treatment of <strong>B</strong>-NHLs/<strong>CLL</strong> with demonstrated high clinical efficacy of unmodified, radiolabeled, and bispecific antibodies. Therefore, CD20-targeted CAR …... </span> </p> </li>
  <p style="text-align: center;"><a href="https://leadingviet.com/link-out/aHR0cHM6Ly9hc2hwdWJsaWNhdGlvbnMub3JnL2Jsb29kL2FydGljbGUvMTM4L1N1cHBsZW1lbnQlMjAxLzM4NzIvNDgxMDU1L1NhZmV0eS1hbmQtRWZmaWNhY3ktb2YtVGhpcmQtR2VuZXJhdGlvbi1DRDIw" style="background-color: #009dea;color: white;padding: 10px 15px;text-decoration: none;text-transform: uppercase;border-radius: 5px;text-align: center;margin: 0;"> Xem thêm</a></p>
 </ul>
</div><!--ads_tag-->
<p><br></p>
<p>
 <lite-youtube videoid="Gp54zTVKDdU" style="background-image: url('https://i.ytimg.com/vi/Gp54zTVKDdU/hqdefault.jpg');"> 
  <a class="lty-playbtn" title="Investigating TG-1701, a novel BTKi, in CLL and NHL"> <span class="lyt-visually-hidden">Investigating TG-1701, a novel BTKi, in CLL and NHL</span> </a>
 </lite-youtube></p>
<p></p>
<h2 id="h2_13">10. B-Cell Lymphoma Types: In-Depth List of Lymphoma Classifications</h2>
<div id="content" style="display: inline-block;background: #eff5f9;border: 1px solid #9cd5f4;border-radius: 4px;/*! width: 52%; */padding: 1.5%;margin-bottom: 10px;font-size: 14px;padding: 10px 10px 10px 20px;">
 <ul id="ul_content"> 
  <li> <p><strong>Tác giả: </strong> www.lymphomainfo.net </p></li> 
  <li> <p><strong> Ngày đăng: </strong> 25/8/2022 </p></li>
  <li> <p><strong> Lượt xem: </strong> 2873 </p></li> 
  <li> <p><strong>Đánh giá: </strong> 2 ⭐ ( 32091 lượt đánh giá ) </p></li>
  <li> <p><strong>Xếp hạng cao nhất : </strong> 5 ⭐ </p></li> 
  <li> <p><strong>Xếp hạng thấp nhất : </strong> 4 ⭐ </p></li> 
  <li> <p><strong>Mô tả bài viết: </strong><span class="content"> Angiocentric Lymphoma - Pulmonary <strong>B</strong> Cell; Chronic Lymphocytic Leukemia (<strong>CLL</strong>) Small Lymphocytic Lymphoma (SLL) Precursor <strong>B</strong>-lymphoblastic lymphoma; Causes and Risk …... </span> </p> </li>
  <p style="text-align: center;"><a href="https://leadingviet.com/link-out/aHR0cHM6Ly93d3cubHltcGhvbWFpbmZvLm5ldC9uaGwvYi1jZWxsLmh0bWw=" style="background-color: #009dea;color: white;padding: 10px 15px;text-decoration: none;text-transform: uppercase;border-radius: 5px;text-align: center;margin: 0;"> Xem thêm</a></p>
 </ul>
</div>
<p><br></p>
<p>
 <lite-youtube videoid="KNcypxyowWA" style="background-image: url('https://i.ytimg.com/vi/KNcypxyowWA/hqdefault.jpg');"> 
  <a class="lty-playbtn" title="Chronic Lymphocytic Leukemia (CLL)"> <span class="lyt-visually-hidden">Chronic Lymphocytic Leukemia (CLL)</span> </a>
 </lite-youtube></p>
<p></p>
<h2 id="h2_14">11. Study to Assess Safety, Tolerability and Efficacy of MB-106 in …</h2>
<div id="content" style="display: inline-block;background: #eff5f9;border: 1px solid #9cd5f4;border-radius: 4px;/*! width: 52%; */padding: 1.5%;margin-bottom: 10px;font-size: 14px;padding: 10px 10px 10px 20px;">
 <ul id="ul_content"> 
  <li> <p><strong>Tác giả: </strong> clinicaltrials.gov </p></li> 
  <li> <p><strong> Ngày đăng: </strong> 25/4/2022 </p></li>
  <li> <p><strong> Lượt xem: </strong> 74710 </p></li> 
  <li> <p><strong>Đánh giá: </strong> 1 ⭐ ( 62178 lượt đánh giá ) </p></li>
  <li> <p><strong>Xếp hạng cao nhất : </strong> 5 ⭐ </p></li> 
  <li> <p><strong>Xếp hạng thấp nhất : </strong> 3 ⭐ </p></li> 
  <li> <p><strong>Mô tả bài viết: </strong><span class="content"> <span class="news_dt">04/05/2022</span>&nbsp;· Arm 1: Patients with aggressive <strong>B</strong>-cell non-Hodgkin lymphoma (<strong>NHL</strong>) including, but not limited to, diffuse large <strong>B</strong>-cell lymphoma (DLBCL) and mantle cell lymphoma (MCL). Arm 2: …... </span> </p> </li>
  <p style="text-align: center;"><a href="https://leadingviet.com/link-out/aHR0cHM6Ly9jbGluaWNhbHRyaWFscy5nb3YvY3QyL3Nob3cvTkNUMDUzNjAyMzg=" style="background-color: #009dea;color: white;padding: 10px 15px;text-decoration: none;text-transform: uppercase;border-radius: 5px;text-align: center;margin: 0;"> Xem thêm</a></p>
 </ul>
</div><!--ads_tag-->
<p><br></p>
<p>
 <lite-youtube videoid="A2s7sB4li4s" style="background-image: url('https://i.ytimg.com/vi/A2s7sB4li4s/hqdefault.jpg');"> 
  <a class="lty-playbtn" title="NHL and CLL Treatment Mode of Action Animation"> <span class="lyt-visually-hidden">NHL and CLL Treatment Mode of Action Animation</span> </a>
 </lite-youtube></p>
<p></p>
<h2 id="h2_15">12. A Study of BN102 in Patients With Previously Treated CLL/SLL …</h2>
<div id="content" style="display: inline-block;background: #eff5f9;border: 1px solid #9cd5f4;border-radius: 4px;/*! width: 52%; */padding: 1.5%;margin-bottom: 10px;font-size: 14px;padding: 10px 10px 10px 20px;">
 <ul id="ul_content"> 
  <li> <p><strong>Tác giả: </strong> clinicaltrials.gov </p></li> 
  <li> <p><strong> Ngày đăng: </strong> 18/3/2022 </p></li>
  <li> <p><strong> Lượt xem: </strong> 75266 </p></li> 
  <li> <p><strong>Đánh giá: </strong> 1 ⭐ ( 97525 lượt đánh giá ) </p></li>
  <li> <p><strong>Xếp hạng cao nhất : </strong> 5 ⭐ </p></li> 
  <li> <p><strong>Xếp hạng thấp nhất : </strong> 2 ⭐ </p></li> 
  <li> <p><strong>Mô tả bài viết: </strong><span class="content"> <span class="news_dt">09/05/2022</span>&nbsp;· A Multicenter Phase 1/2 Clinical Study to Evaluate the Safety and Efficacy of BN102 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic …... </span> </p> </li>
  <p style="text-align: center;"><a href="https://leadingviet.com/link-out/aHR0cHM6Ly9jbGluaWNhbHRyaWFscy5nb3YvY3QyL3Nob3cvTkNUMDUzNjUxMDA=" style="background-color: #009dea;color: white;padding: 10px 15px;text-decoration: none;text-transform: uppercase;border-radius: 5px;text-align: center;margin: 0;"> Xem thêm</a></p>
 </ul>
</div>
<p><br></p>
<p>
 <lite-youtube videoid="RjdPUP7AN98" style="background-image: url('https://i.ytimg.com/vi/RjdPUP7AN98/hqdefault.jpg');"> 
  <a class="lty-playbtn" title="Positive results in phase II study of copanlisib treating NHL and CLL"> <span class="lyt-visually-hidden">Positive results in phase II study of copanlisib treating NHL and CLL</span> </a>
 </lite-youtube></p>
<p></p>
<h2 id="h2_16">13. T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL</h2>
<div id="content" style="display: inline-block;background: #eff5f9;border: 1px solid #9cd5f4;border-radius: 4px;/*! width: 52%; */padding: 1.5%;margin-bottom: 10px;font-size: 14px;padding: 10px 10px 10px 20px;">
 <ul id="ul_content"> 
  <li> <p><strong>Tác giả: </strong> clinicaltrials.gov </p></li> 
  <li> <p><strong> Ngày đăng: </strong> 20/6/2022 </p></li>
  <li> <p><strong> Lượt xem: </strong> 77053 </p></li> 
  <li> <p><strong>Đánh giá: </strong> 5 ⭐ ( 90436 lượt đánh giá ) </p></li>
  <li> <p><strong>Xếp hạng cao nhất : </strong> 5 ⭐ </p></li> 
  <li> <p><strong>Xếp hạng thấp nhất : </strong> 3 ⭐ </p></li> 
  <li> <p><strong>Mô tả bài viết: </strong><span class="content"> <span class="news_dt">03/07/2008</span>&nbsp;· Recurrent low or intermediate grade <strong>B</strong>-cell lymphoma or <strong>B</strong>-<strong>CLL</strong>, or newly diagnosed patients unable to receive or complete standard therapy OR diagnosis of relapsed/refractory …... </span> </p> </li>
  <p style="text-align: center;"><a href="https://leadingviet.com/link-out/aHR0cHM6Ly9jbGluaWNhbHRyaWFscy5nb3YvY3QyL3Nob3cvTkNUMDA3MDkwMzM=" style="background-color: #009dea;color: white;padding: 10px 15px;text-decoration: none;text-transform: uppercase;border-radius: 5px;text-align: center;margin: 0;"> Xem thêm</a></p>
 </ul>
</div><!--ads_tag-->
<p><br></p>
<p>
 <lite-youtube videoid="dJuHM3lhAGE" style="background-image: url('https://i.ytimg.com/vi/dJuHM3lhAGE/hqdefault.jpg');"> 
  <a class="lty-playbtn" title="Dr  David Spaner - CLL Diagnosis and Managing Symptoms"> <span class="lyt-visually-hidden">Dr David Spaner - CLL Diagnosis and Managing Symptoms</span> </a>
 </lite-youtube></p>
<p></p>
<h2 id="h2_17">14. First Patient Treated in Trial of CD20-Targeted CAR T Cells in B …</h2>
<div id="content" style="display: inline-block;background: #eff5f9;border: 1px solid #9cd5f4;border-radius: 4px;/*! width: 52%; */padding: 1.5%;margin-bottom: 10px;font-size: 14px;padding: 10px 10px 10px 20px;">
 <ul id="ul_content"> 
  <li> <p><strong>Tác giả: </strong> www.targetedonc.com </p></li> 
  <li> <p><strong> Ngày đăng: </strong> 2/1/2022 </p></li>
  <li> <p><strong> Lượt xem: </strong> 62436 </p></li> 
  <li> <p><strong>Đánh giá: </strong> 2 ⭐ ( 86213 lượt đánh giá ) </p></li>
  <li> <p><strong>Xếp hạng cao nhất : </strong> 5 ⭐ </p></li> 
  <li> <p><strong>Xếp hạng thấp nhất : </strong> 1 ⭐ </p></li> 
  <li> <p><strong>Mô tả bài viết: </strong><span class="content"> <span class="news_dt">14/10/2022</span>&nbsp;· A multicenter trial of the CAR T-cell product MB-106 has treated its first patient, Mustang Bio, Inc announced. Investigators of a trial for B-cell non-Hodgkin lymphoma <strong>(B-NHL)</strong> …... </span> </p> </li>
  <p style="text-align: center;"><a href="https://leadingviet.com/link-out/aHR0cHM6Ly93d3cudGFyZ2V0ZWRvbmMuY29tL3ZpZXcvZmlyc3QtcGF0aWVudC10cmVhdGVkLWluLXRyaWFsLW9mLWNkMjAtdGFyZ2V0ZWQtY2FyLXQtY2VsbHMtaW4tYi1uaGwtY2xs" style="background-color: #009dea;color: white;padding: 10px 15px;text-decoration: none;text-transform: uppercase;border-radius: 5px;text-align: center;margin: 0;"> Xem thêm</a></p>
 </ul>
</div>
<p><br></p>
<p>
 <lite-youtube videoid="QsoVB2dNmtQ" style="background-image: url('https://i.ytimg.com/vi/QsoVB2dNmtQ/hqdefault.jpg');"> 
  <a class="lty-playbtn" title="The Role of B-Cell Inhibitors in CLL"> <span class="lyt-visually-hidden">The Role of B-Cell Inhibitors in CLL</span> </a>
 </lite-youtube></p>
<p></p>
<h2 id="h2_18">15. HL, NHL, MM......一文简单介绍淋巴瘤和骨髓瘤 - 上海儒百生物科 …</h2>
<div id="content" style="display: inline-block;background: #eff5f9;border: 1px solid #9cd5f4;border-radius: 4px;/*! width: 52%; */padding: 1.5%;margin-bottom: 10px;font-size: 14px;padding: 10px 10px 10px 20px;">
 <ul id="ul_content"> 
  <li> <p><strong>Tác giả: </strong> www.schbio.com </p></li> 
  <li> <p><strong> Ngày đăng: </strong> 8/1/2022 </p></li>
  <li> <p><strong> Lượt xem: </strong> 60733 </p></li> 
  <li> <p><strong>Đánh giá: </strong> 2 ⭐ ( 29836 lượt đánh giá ) </p></li>
  <li> <p><strong>Xếp hạng cao nhất : </strong> 5 ⭐ </p></li> 
  <li> <p><strong>Xếp hạng thấp nhất : </strong> 1 ⭐ </p></li> 
  <li> <p><strong>Mô tả bài viết: </strong><span class="content"> 淋巴瘤一般可分为霍奇金淋巴瘤（HL，占淋巴瘤的8%~11%）和非霍奇金淋巴瘤（<strong>NHL</strong>，占淋巴瘤的89%~91%），这两者的区别其实就是前者是由点及面，而后者是多点并进： HL通常比较局 …... </span> </p> </li>
  <p style="text-align: center;"><a href="https://leadingviet.com/link-out/aHR0cHM6Ly93d3cuc2NoYmlvLmNvbS9oLW5kLTU3Lmh0bWw=" style="background-color: #009dea;color: white;padding: 10px 15px;text-decoration: none;text-transform: uppercase;border-radius: 5px;text-align: center;margin: 0;"> Xem thêm</a></p>
 </ul>
</div><!--ads_tag-->
<p><br></p>
<p>
 <lite-youtube videoid="n21ajMK0U9c" style="background-image: url('https://i.ytimg.com/vi/n21ajMK0U9c/hqdefault.jpg');"> 
  <a class="lty-playbtn" title="What is Chronic lymphocytic leukaemia (CLL) / Small lymphocytic lymphoma (SLL)?"> <span class="lyt-visually-hidden">What is Chronic lymphocytic leukaemia (CLL) / Small lymphocytic lymphoma (SLL)?</span> </a>
 </lite-youtube></p>
<p></p>
<h2 id="h2_19">16. NHL &amp; CLL Treatment Option | RIABNI™ (rituximab-arrx)</h2>
<div id="content" style="display: inline-block;background: #eff5f9;border: 1px solid #9cd5f4;border-radius: 4px;/*! width: 52%; */padding: 1.5%;margin-bottom: 10px;font-size: 14px;padding: 10px 10px 10px 20px;">
 <ul id="ul_content"> 
  <li> <p><strong>Tác giả: </strong> www.riabni.com </p></li> 
  <li> <p><strong> Ngày đăng: </strong> 11/5/2022 </p></li>
  <li> <p><strong> Lượt xem: </strong> 19054 </p></li> 
  <li> <p><strong>Đánh giá: </strong> 5 ⭐ ( 71179 lượt đánh giá ) </p></li>
  <li> <p><strong>Xếp hạng cao nhất : </strong> 5 ⭐ </p></li> 
  <li> <p><strong>Xếp hạng thấp nhất : </strong> 4 ⭐ </p></li> 
  <li> <p><strong>Mô tả bài viết: </strong><span class="content"> RIABNI™ is a prescription medicine used to treat: Adults with Non-Hodgkin's Lymphoma (<strong>NHL</strong>): alone or with other chemotherapy medicines. Adults with Chronic Lymphocytic Leukemia …... </span> </p> </li>
  <p style="text-align: center;"><a href="https://leadingviet.com/link-out/aHR0cHM6Ly93d3cucmlhYm5pLmNvbS9wYXRpZW50L29uY29sb2d5L25obC1hbmQtY2xsLXRyZWF0bWVudA==" style="background-color: #009dea;color: white;padding: 10px 15px;text-decoration: none;text-transform: uppercase;border-radius: 5px;text-align: center;margin: 0;"> Xem thêm</a></p>
 </ul>
</div>
<p><br></p>
<p>
 <lite-youtube videoid="Am6RQTfkt5w" style="background-image: url('https://i.ytimg.com/vi/Am6RQTfkt5w/hqdefault.jpg');"> 
  <a class="lty-playbtn" title="An exciting time for CAR T-cell therapy: promising results for B-ALL, nHL and CLL"> <span class="lyt-visually-hidden">An exciting time for CAR T-cell therapy: promising results for B-ALL, nHL and CLL</span> </a>
 </lite-youtube></p>
<p></p>
<h2 id="h2_20">17. Indolent (slow-growing) B-cell NHL - Lymphoma Australia</h2>
<div id="content" style="display: inline-block;background: #eff5f9;border: 1px solid #9cd5f4;border-radius: 4px;/*! width: 52%; */padding: 1.5%;margin-bottom: 10px;font-size: 14px;padding: 10px 10px 10px 20px;">
 <ul id="ul_content"> 
  <li> <p><strong>Tác giả: </strong> www.lymphoma.org.au </p></li> 
  <li> <p><strong> Ngày đăng: </strong> 2/7/2022 </p></li>
  <li> <p><strong> Lượt xem: </strong> 59260 </p></li> 
  <li> <p><strong>Đánh giá: </strong> 5 ⭐ ( 61648 lượt đánh giá ) </p></li>
  <li> <p><strong>Xếp hạng cao nhất : </strong> 5 ⭐ </p></li> 
  <li> <p><strong>Xếp hạng thấp nhất : </strong> 2 ⭐ </p></li> 
  <li> <p><strong>Mô tả bài viết: </strong><span class="content"> Most indolent lymphomas are a subtype of non-Hodgkin lymphoma (<strong>NHL</strong>), however there is one subtype of Hodgkin lymphoma called Nodular Lymphocyte Predominant Hodgkin Lymphoma …... </span> </p> </li>
  <p style="text-align: center;"><a href="https://leadingviet.com/link-out/aHR0cHM6Ly93d3cubHltcGhvbWEub3JnLmF1L3R5cGVzLW9mLWx5bXBob21hL25vbi1ob2Rna2luLWx5bXBob21hL2luZG9sZW50LXNsb3ctZ3Jvd2luZy1iLWNlbGwtbmhsLw==" style="background-color: #009dea;color: white;padding: 10px 15px;text-decoration: none;text-transform: uppercase;border-radius: 5px;text-align: center;margin: 0;"> Xem thêm</a></p>
 </ul>
</div><!--ads_tag-->
<p><br></p>
<p>
 <lite-youtube videoid="QB1e6JpFbow" style="background-image: url('https://i.ytimg.com/vi/QB1e6JpFbow/hqdefault.jpg');"> 
  <a class="lty-playbtn" title="TGR-1202, ublituximab and ibrutinib combination for advanced CLL and NHL"> <span class="lyt-visually-hidden">TGR-1202, ublituximab and ibrutinib combination for advanced CLL and NHL</span> </a>
 </lite-youtube></p>
<p></p>
<h2 id="h2_21">18. Chronische Lymphatische Leukämie (CLL) — Onkopedia</h2>
<div id="content" style="display: inline-block;background: #eff5f9;border: 1px solid #9cd5f4;border-radius: 4px;/*! width: 52%; */padding: 1.5%;margin-bottom: 10px;font-size: 14px;padding: 10px 10px 10px 20px;">
 <ul id="ul_content"> 
  <li> <p><strong>Tác giả: </strong> www.onkopedia.com </p></li> 
  <li> <p><strong> Ngày đăng: </strong> 7/7/2022 </p></li>
  <li> <p><strong> Lượt xem: </strong> 80600 </p></li> 
  <li> <p><strong>Đánh giá: </strong> 5 ⭐ ( 93603 lượt đánh giá ) </p></li>
  <li> <p><strong>Xếp hạng cao nhất : </strong> 5 ⭐ </p></li> 
  <li> <p><strong>Xếp hạng thấp nhất : </strong> 4 ⭐ </p></li> 
  <li> <p><strong>Mô tả bài viết: </strong><span class="content"> Die Chronische lymphatische Leukämie <strong>(CLL</strong>) ist die häufigste leukämische Erkrankung in Mitteleuropa. Die <strong>CLL</strong> ist klinisch und biologisch heterogen. Das mediane Erkrankungsalter …... </span> </p> </li>
  <p style="text-align: center;"><a href="https://leadingviet.com/link-out/aHR0cHM6Ly93d3cub25rb3BlZGlhLmNvbS9kZS9vbmtvcGVkaWEvZ3VpZGVsaW5lcy9jaHJvbmlzY2hlLWx5bXBoYXRpc2NoZS1sZXVrYWVtaWUtY2xs" style="background-color: #009dea;color: white;padding: 10px 15px;text-decoration: none;text-transform: uppercase;border-radius: 5px;text-align: center;margin: 0;"> Xem thêm</a></p>
 </ul>
</div>
<p><br></p>
<p>
 <lite-youtube videoid="q4-8UCKxIZI" style="background-image: url('https://i.ytimg.com/vi/q4-8UCKxIZI/hqdefault.jpg');"> 
  <a class="lty-playbtn" title="How Non-Hodgkin Lymphoma Affects Your Body &amp; Risk Factors to Know | Stanford"> <span class="lyt-visually-hidden">How Non-Hodgkin Lymphoma Affects Your Body &amp; Risk Factors to Know | Stanford</span> </a>
 </lite-youtube></p>
<p></p>
<h2 id="h2_22">19. Monoclonal B Cell Lymphocytosis - CLL / NHL</h2>
<div id="content" style="display: inline-block;background: #eff5f9;border: 1px solid #9cd5f4;border-radius: 4px;/*! width: 52%; */padding: 1.5%;margin-bottom: 10px;font-size: 14px;padding: 10px 10px 10px 20px;">
 <ul id="ul_content"> 
  <li> <p><strong>Tác giả: </strong> www.cll-nhl.com </p></li> 
  <li> <p><strong> Ngày đăng: </strong> 15/5/2022 </p></li>
  <li> <p><strong> Lượt xem: </strong> 43801 </p></li> 
  <li> <p><strong>Đánh giá: </strong> 4 ⭐ ( 86138 lượt đánh giá ) </p></li>
  <li> <p><strong>Xếp hạng cao nhất : </strong> 5 ⭐ </p></li> 
  <li> <p><strong>Xếp hạng thấp nhất : </strong> 5 ⭐ </p></li> 
  <li> <p><strong>Mô tả bài viết: </strong><span class="content"> <span class="news_dt">05/07/2013</span>&nbsp;· So at the upper range there may be about 4000 lymphocytes and about 10% (around 400 cells) should be <strong>B</strong> cells. These are ballpark estimates and can be fairly variable. In …... </span> </p> </li>
  <p style="text-align: center;"><a href="https://leadingviet.com/link-out/aHR0cDovL3d3dy5jbGwtbmhsLmNvbS8yMDEzLzA3L21vbm9jbG9uYWwtYi1jZWxsLWx5bXBob2N5dG9zaXMuaHRtbA==" style="background-color: #009dea;color: white;padding: 10px 15px;text-decoration: none;text-transform: uppercase;border-radius: 5px;text-align: center;margin: 0;"> Xem thêm</a></p>
 </ul>
</div><!--ads_tag-->
<p><br></p>
<p> </p>
<div class="comment"> 
 <h4>Bình Luận</h4> 
 <div class="ele_comment"> 
  <img src="/image/user/admin-avatar.jpg " alt=""> 
  <form class="input_box" action="#" method="post"> 
   <div class="input">
    <textarea id="editor" placeholder=" Bình Luận..." name="comment_Text"></textarea>
   </div> 
   <div class="send">
    <input type="submit" value="Bình Luận">
   </div>
  </form> 
 </div> 
</div>
</div>

	<footer style="background-color: white;">

		<div id="text-26" class="mh-footer-widget widget_text">
			<h3 class="mh-widget-title mh-footer-widget-title"
				style="text-align: center;">
				<span class="mh-widget-title-inner mh-footer-widget-title-inner">Thông
					tin liên Hệ</span>
			</h3>
			<div class="textwidget">
				<p style="text-align: center;">
					<a th:href="/" target="_blank"><span
						  style="color: red;"><strong>thingkingvbvb</strong></span></a>
				</p>
				<p style="text-align: center;">
					Địa Chỉ: <span style="color: green;" >9999 Ba Đình, Hà Nội</span>
				</p>
				<p style="text-align: center;">
					Điện thoại: <span style="color: green;" >+84971123456</span>
				</p>
			
				<p style="text-align: center;">
					Gmail: <span style="color: #008000;"
						>info@thingkingvbvb.github.io</span>
				</p>
			</div>
		</div>
	</footer>

</body>



</html>

